ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623081 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623081; 2) Community: the network communities that were significantly associated with the response to NSC 623081; 3) Molecule: the relationships between components within communities and NSC 623081; 4) MDR: the compounds that were significantly associated with the NSC 623081.

NSC Compound Enrichment Correlation
NSC 663334 Null 0.0102077332082017 -0.24855406
NSC 678355 L-LYS-L-p-NO2Phe-L-Ala-L-p-NO2PheNH2 0.0102077332082017 0.14091757
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0102077332082017 -0.25646957
NSC 682763 Null 0.0102077332082017 0.017464576
NSC 683558 Camptothecin Derivative 0.0102077332082017 0.092241614
NSC 696558 N-(4-Amino-4-deoxy-N10-methypteroyl)-D,L-homocysteic acid 0.0102077332082017 -0.15624035
NSC 700122 Null 0.0102077332082017 -0.23021199
NSC 710340 6H,7H-[1]Benzopyrano[4,3-b][1]benzopyran-7-one,3,8,10-tri hydroxy-9,11-bis(3-methyl-2-butenyl)-6-(2-methyl-1-propenyl)- (9CI) 0.0102077332082017 0.0007831331
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0102077332082017 0.11207227
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.0102077332082017 0.30911069
Total:119  Current:23    [First] [Prev] [Next] [Last]